| Financial Year |
March 31 2023 |
| Monetary Funds |
313,076,952.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,136,333.94 |
| Accounts Receivable |
628,481,586.64 |
| Advances to Suppliers |
7,868,953.20 |
| Other Receivables |
15,023,602.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
124,304,521.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,784,594.65 |
| Total Current Assets |
1,096,676,544.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,525,131.82 |
| Investment Properties |
-- |
| Fixed Assetes |
21,847,050.40 |
| Under-construction Projects |
3,530,603.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
220,897,442.00 |
| R&D expenses |
-- |
| Goodwill |
76,316,228.57 |
| Long-Term Deferred and Prepaid Expenses |
1,275,895.72 |
| Deferred Income Tax Assets |
15,876,326.20 |
| Other Non-Current Assets |
1,972,349.00 |
| Sub-Total of Non-Current Assets |
349,697,943.40 |
| Total Assets |
1,446,374,487.87 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
23,230,275.90 |
| Accounts Payable |
95,298,369.23 |
| Accounts Received In Advance |
24,981.14 |
| Employee Compensation Payable |
15,169,368.24 |
| Taxes Payable |
14,739,715.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
66,632,745.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,595,441.84 |
| Other Current Liabilities |
10,090,204.69 |
| Sub-Total of Current Liabilities |
276,999,722.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
804,686.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
859,475.49 |
| Total Liabilities |
277,859,197.61 |
| Paid-In Capital(Or Share Stock) |
308,647,340.00 |
| Capital Surplus |
407,009,201.28 |
| Surplus Reserve |
62,842,443.64 |
| LESS:Treasury Stock |
20,267,141.49 |
| Undistributed Profits |
387,314,742.84 |
| Minority Stockholder's Interest |
23,965,805.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,144,549,484.52 |
| Owner's Equity（Stockholder's Equity） |
1,168,515,290.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,446,374,487.87 |
